Dr. Michael D. Kohen, MD

Dr. Kohen practices at Allergy, Asthma, Arthritis & Lung Center in Daytona Beach, Florida.

Dr. Kohen's NPI, 1013909951, was assigned on August 17, 2005. Dr. Kohen graduated from University Of Florida College Of Medicine in 1967. Dr. Kohen holds Florida license ME0013677.

Dr. Kohen's primary practice is Allergy, Asthma, Arthritis & Lung Center, at 709 N Clyde Morris Blvd, Daytona Beach, FL 32114-1603. The practice phone is (386) 252-1632.

Dr. Kohen's primary practice is Allergy, Asthma, Arthritis & Lung Center in Daytona Beach, Florida. Dr. Kohen is also affiliated with AdventHealth Daytona Beach. The medical group on file is Allergy, Asthma, Arthritis & Lung Center. Dmand AI also links Dr. Kohen to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kohen practices, 8 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Kohen's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Kohen is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Kohen's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Kohen treats.

CMS data shows 196,942 Medicare services from Dr. Kohen across 19 procedure codes in 2024, for 739 Medicare patients. Medicare paid $954,232 for them.

CMS counts 739 Medicare patients who saw Dr. Kohen in 2024. The largest group is 65 to 74, with 315 patients. 75% of them have arthritis, and 75% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kohen's median patient age at 73, with 74% women.

In 2024, Dr. Kohen wrote 5,276 Medicare Part D claims for 845 patients. 83% of them were for generic drugs. CMS names the drug for 4,830 of them, across 73 drugs with 11 or more claims each, at $1,918,978 in total drug cost. In 2023, CMS named 5,109 claims across 77 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kohen for performance year 2024, reported individually. Dr. Kohen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Kohen in 2012. The most frequent topics are Antirheumatic Agents, Arthritis, Rheumatoid and Double-Blind Method. Dr. Kohen's most frequent co-authors are Mark Christopher Genovese, MD, Jeffrey L. Kaine, MD and Mitchell Brian Lowenstein, MD.

Dmand AI links Dr. Kohen to 5 clinical trials. Conditions studied include Lupus Erythematosus, Systemic and Connective Tissue Diseases. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Kohen that name 2 trials.

CMS Open Payments shows 1,794 general payments to Dr. Kohen from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $4,383. It also lists 3 research payments totaling $5,282 from 2016 to 2020, naming 2 clinical trials.

Dmand AI lists 4 awards for Dr. Kohen, most recently CMS Stage 1 EHR in 2013.

Dr. Kohen graduated from University Of Florida College Of Medicine in 1967. Dr. Kohen is a member of AAAAI and ACR.

Dr. Kohen is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.